The trademark SMECTIZORB was filed by Hestevard LLP, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on May 10, 2021, and received one opposition filed on August 10, 2021 by Ipsen Consumer HealthCare on Likelihood of confusion. the opponent was represented by Bernard-Boyle, Hélène and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 10, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).